Hypomagnesemia in Chronic Kidney Disease Stage 5

Journal Title: Нирки - Year 2016, Vol 1, Issue 15

Abstract

The article describes the clinical case of correction of hypomagnesemia in a patient 49 years with chronic kidney disease stage 5 with application magnesium orotate.

Authors and Affiliations

Z. V. Babenko

Keywords

Related Articles

Chronic kidney disease and anemia: application of ferrous bisglycinate chelate for correction of iron deficiency in patients with chronic kidney disease

Anemia is a component of chronic kidney disease, having erythropoietin- and iron deficiency nature. 2012 KDIGO guidelines determine anemia as a hemoglobin concentration < 120 g/l in women and < 130 g/l in men. An iron de...

Renin angiotensin-aldosterone system blockers: chronic kidney disease and cardiovascular risk

Reducing the risk of cardiovascular events is one of the most topical issues of modern medicine. Patients with chronic kidney disease stage 3 or lower, according to international guidelines, refer to the group with high...

Kidney Damage in Hemorrhagic Vasculitis Occurring in Childhood and Adulthood

Introduction. Nephropathy is diagnosed in 30–60 % of patients with hemorrhagic vasculitis (HV) (Schönlein Henoch puprupa) and occurred in each fourth of them in the onset of the disease and with the same incidence at fir...

Download PDF file
  • EP ID EP208433
  • DOI -
  • Views 95
  • Downloads 0

How To Cite

Z. V. Babenko (2016). Hypomagnesemia in Chronic Kidney Disease Stage 5. Нирки, 1(15), 105-106. https://europub.co.uk/articles/-A-208433